1. Lenz W. A short history of thalidomide embryopathy. Terratology. 1988;38(3):203–15.
2. Vargesson N. Thalidomide embryopathy: an enigmatic challenge. ISRN Dev Biol. 2013;2013:1–18. https://doi.org/10.1155/2013/241016 .
3. World Health Organization A short history of involvement in drug safety monitoring by WHO. In: The importance of pharmacovigilance. Safety monitoring of medicinal products, World Health Organization, Geneva, Switzerland: 2002, p. 5
4. World Health Organization. Handbook of resolutions and decisions of the World Health Assembly and Executive Board, Vol 11948–1972. Geneva: World Health Organization; 1973 (WHA16.36 Clinical and pharmacological Evaluation of Drugs).
5. World Health Organization. International drug monitoring: the role of national centres (WHO technical report series No. 498). Geneva: World Health Organization; 1972.